Midas Management’s Elevance Health ELV Stock Holding History

Midas Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-17,100	Closed	-$2.25M	–	151
2016 Q2	$2.25M	Hold	17,100	–	–	1.27%	14
2016 Q1	$2.38M	Hold	17,100	–	–	1.23%	13
2015 Q4	$2.38M	Hold	17,100	–	–	1.42%	9
2015 Q3	$2.39M	Hold	17,100	–	–	1.54%	8
2015 Q2	$2.81M	Hold	17,100	–	–	1.51%	7
2015 Q1	$2.64M	Hold	17,100	–	–	1.32%	8
2014 Q4	$2.15M	Hold	17,100	–	–	1.12%	20
2014 Q3	$2.05M	Hold	17,100	–	–	1.14%	22
2014 Q2	$1.84M	Hold	17,100	–	–	1.19%	25
2014 Q1	$1.7M	Buy	+17,100	New	+$1.55M	0.79%	46

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Midas Management's ELV Position: Q3 2016 in Review

Midas Management sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 17,100 shares — an estimated $2.25M sold.

Midas Management first reported a position in ELV in Q1 2014 and held it in 10 quarters. The position peaked at $2.81M in Q2 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

Midas Management reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
Midas Management sold 17,100 Elevance Health shares in Q3 2016, an estimated $2.25M.
Midas Management first reported a position in Elevance Health in Q1 2014 and held it in 10 quarters.
Midas Management's Elevance Health position peaked at $2.81M in Q2 2015.
737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Midas Management's 13F filing for Q3 2016, filed 24 Oct 2016.